It's good to hear your views dgmore.

From September 15 after a period of assessment PTI business objectives were pivoted by Dr Venkatesan the company's newly appointed CEO,.  His new objective was to take POET IP from lab to fab to commercialise by building AOC for the burgeoning Data Centre market. From that moment it was clear that a new company project was started requiring a new business plan (BP) to achieve.

 The BP was to grow finacialy by aquisition to fund the commercialisation and development of POET.  It didn't work as the Anadigics purchase failed and later the Denselight aquisition proved to be underfunded, inadequately equiped and manned, requiring the additional capital funding.  This created  the unpopular but essential step needed in the PO to acquire more capital to get up and running which has left the share price languishing. 

As matters go the present state of this company is as DGMORE says 'on the verge'.  Business risk has not been eliminated but structurely the company is now in a position to begin delivering products to market DL &'BB first followed by POET detectors, then in 2018 the optimised AOC.  

As a gamble this company, at the current SP is very attractive for a any punter who is not risk averse. It is too early for instutional investors to dive in that is until the company can demonstrate financial growth and technical uniqueness. I would say the course is set fair to achieve this if the ship is sound enough to weather the storms.

Here's the intrigue in the POET saga. Before the pivot in direction this company was set up to sell it's IP which was substantially PET.   All indications point to the PET project development being completed and capable of trasfer as PDK and mass manufacture at that time. The question is did this happen or not? Certainly that prospect remained open whilst the TRAB operated but as we can see from the time needed to comercialise POET, a 40 engineer project would be nearing some sort of  conclusion by now with a possible development partner or partners. This retains the possibility of NRE payments and royalties.  I don't rely on this in my assement of PTI as an investment but I cannot eliminate it's possibility.

On this basis PTI remains a hold. I don't accept that SP doldrums is anything other than a holding pattern untill at least two quarters financials in 2017 have been published when PTI can be more realistically assessed for progress by those institutions watching. Positive indicators then or a nice surprise announcement before could jolt the SP into movement forward. 

That's my two penneth.

Sula